Literature DB >> 10207726

A role for transcription factor NF-kappa B in intestinal inflammation.

A J Schottelius1, A S Baldwin.   

Abstract

Nuclear factor (NF) kappa B is a transcription factor that controls the transcription of a variety of cellular genes regulating the inflammatory response. Many proinflammatory cytokines are transcriptionally regulated by NF-kappa B, and their increased expression has been implicated in the pathogenesis of inflammatory bowel disease (IBD). Even though it seemed clear that the increase in proinflammatory cytokine production in IBD is crucial for the initiation and perpetuation of chronic intestinal inflammation, the elements governing this dysregulation of enhanced cytokine production remained unclear. This review discusses a series of recent studies that demonstrate the activation of NF-kappa B in the inflamed mucosa, and that shed new light on the central pathogenic role of NF-kappa B in chronic intestinal inflammation. In addition to describing the activation of NF-kappa B, excitement has been generated by reports that define the molecular targets of anti-inflammatory agents, and that demonstrate the effective blockade of NF-kappa B in intestinal inflammation. These new insights into the activation and inhibition of NF-kappa B have opened new and promising avenues for a more specific treatment of chronic intestinal inflammation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10207726     DOI: 10.1007/s003840050178

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  40 in total

1.  Functional genomics in gastroenterology.

Authors:  S Schreiber; J Hampe; H Eickhoff; H Lehrach
Journal:  Gut       Date:  2000-11       Impact factor: 23.059

2.  Etiology of inflammatory bowel syndrome.

Authors:  A Raedler
Journal:  Int J Colorectal Dis       Date:  2001-09       Impact factor: 2.571

3.  The p50-p50 NF-kappaB complex as a stimulus-specific repressor of gene activation.

Authors:  Xin Tong; Lei Yin; Raymond Washington; Daniel W Rosenberg; Charles Giardina
Journal:  Mol Cell Biochem       Date:  2004-10       Impact factor: 3.396

4.  Dextran sulfate sodium-induced colitis is associated with enhanced low molecular mass polypeptide 2 (LMP2) expression and is attenuated in LMP2 knockout mice.

Authors:  Leo R Fitzpatrick; Vineeta Khare; Jeffrey S Small; Walter A Koltun
Journal:  Dig Dis Sci       Date:  2006-07       Impact factor: 3.199

Review 5.  Polyphenols in the treatment of inflammatory bowel disease and acute pancreatitis.

Authors:  Haim Shapiro; Pierre Singer; Zamir Halpern; Rafael Bruck
Journal:  Gut       Date:  2006-08-24       Impact factor: 23.059

6.  NF-kappaB activation precedes increases in mRNA encoding neurokinin-1 receptor, proinflammatory cytokines, and adhesion molecules in dextran sulfate sodium-induced colitis in rats.

Authors:  Karen L Reed; A Brent Fruin; Adam C Gower; Kelly D Gonzales; Arthur F Stucchi; Christopher D Andry; Michael O'Brien; James M Becker
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

7.  The major pathway by which polymeric formula reduces inflammation in intestinal epithelial cells: a microarray-based analysis.

Authors:  Lily Nahidi; Susan M Corley; Marc R Wilkins; Jerry Wei; Moftah Alhagamhmad; Andrew S Day; Daniel A Lemberg; Steven T Leach
Journal:  Genes Nutr       Date:  2015-07-17       Impact factor: 5.523

8.  Osteoprotegerin exerts its pro-inflammatory effects through nuclear factor-κB activation.

Authors:  Lily Nahidi; Steven T Leach; Daniel A Lemberg; Andrew S Day
Journal:  Dig Dis Sci       Date:  2013-09-19       Impact factor: 3.199

9.  Up-regulation of intestinal nuclear factor kappa B and intercellular adhesion molecule-1 following traumatic brain injury in rats.

Authors:  Chun-Hua Hang; Ji-Xin Shi; Jie-Shou Li; Wei-Qin Li; Hong-Xia Yin
Journal:  World J Gastroenterol       Date:  2005-02-28       Impact factor: 5.742

10.  Expression of catalytic proteasome subunits in the gut of patients with Crohn's disease.

Authors:  Alexander Visekruna; Nadia Slavova; Sonja Dullat; Jörn Gröne; Anton-Josef Kroesen; Jörg-Peter Ritz; Heinz-Johannes Buhr; Ulrich Steinhoff
Journal:  Int J Colorectal Dis       Date:  2009-03-10       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.